savolitinib
Showing 1 - 23 of 23
Healthy Male Subjects Trial in Brooklyn (Savolitinib, Fluvoxamine)
Not yet recruiting
- Healthy Male Subjects
- Savolitinib
- Fluvoxamine
-
Brooklyn, MarylandResearch Site
May 25, 2023
NSCLC Trial in Guangzhou (Savolitinib, Docetaxel)
Not yet recruiting
- Non-small Cell Lung Cancer
- Savolitinib
- Docetaxel
-
Guangzhou, Guangdong, ChinaDepartment of Thoracic Surgery and Oncology, The First Affiliate
Mar 17, 2023
Healthy Male Subjects Trial (Savolitinib, Digoxin, Metformin Hydrochloride)
Not yet recruiting
- Healthy Male Subjects
- Savolitinib
- +4 more
- (no location specified)
Mar 3, 2023
Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)
Recruiting
- Stomach Cancer, Adenocarcinoma
- Durvalumab
- Savolitinib
-
Seoul, Korea, Republic ofSamsung Medical Center
Jan 10, 2023
NSCLC Trial in Guangzhou (Savolitinib, Placebo)
Recruiting
- Non-small Cell Lung Cancer
- Savolitinib
- Placebo
-
Guangzhou, ChinaGuangdong General Hospital
Nov 29, 2021
NSCLC Trial in Guangzhou (Osimertinib, Savolitinib)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Osimertinib
- Savolitinib
-
Guangzhou, Guangdong, ChinaGuangdong Lung Cancer Institute, Guangdong General Hospital, Gua
Dec 6, 2021
Gastric Cancer, Esophagogastric Junction Disorder Trial in Beijing (Savolitinib)
Recruiting
- Gastric Cancer
- Esophagogastric Junction Disorder
- Savolitinib
-
Beijing, Beijing, ChinaBeijing Cancer Hopspital
Aug 30, 2021
Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)
Active, not recruiting
- Renal Clear Cell Carcinoma
- Renal Papillary Cell Carcinoma
- Savolitinib
- +2 more
-
London, United KingdomThomas Powles
Aug 10, 2022
NSCLC Metastatic Trial in Shanghai (Savolitinib)
Recruiting
- Non-small Cell Lung Cancer Metastatic
- Savolitinib
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Aug 30, 2021
NSCLC Trial in Marseille (Durvalumab (MEDI4736), Monalizumab (IPH2201), Oleclumab (MEDI9447))
Recruiting
- Non-small Cell Lung Cancer
- Durvalumab (MEDI4736)
- +5 more
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Sep 21, 2022
Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)
Active, not recruiting
- Carcinoma
- +7 more
- Savolitinib
- Sunitinib
-
La Jolla, California
- +58 more
Jan 13, 2023
Lung Sarcomatoid Carcinoma Trial in Beijing, Shanghai (Savolitinib)
Active, not recruiting
- Lung Sarcomatoid Carcinoma
- Savolitinib
-
Beijing, Beijing, China
- +1 more
Nov 29, 2021
Carcinoma, Non-Small-Cell Lung Trial in Worldwide (Savolitinib, Osimertinib, Pemetrexed)
Not yet recruiting
- Carcinoma
- Non-Small-Cell Lung
- Savolitinib
- +4 more
-
Orange City, Florida
- +78 more
Jul 20, 2022
NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Non-small Cell Lung Cancer Metastatic
- AZD2014
- +10 more
-
Avignon, France
- +36 more
Jul 29, 2022
Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7
Active, not recruiting
- Locally Advanced Papillary Renal Cell Carcinoma
- +6 more
- Cabozantinib S-malate
- +3 more
-
Anchorage, Alaska
- +596 more
Aug 2, 2022